Literature DB >> 34340831

CD34+ progenitors are predictive of mortality and are associated with physical activity in cardiovascular disease patients.

David Muggeridge1, Jennifer Dodd2, Mark D Ross3.   

Abstract

BACKGROUND AND AIMS: Circulating progenitor cells (CPCs) play an important role in vascular repair and can influence cardiovascular (CV) health and longevity. Exercise is known to modulate these cells via mobilization from the bone marrow. The primary aims of this study were to evaluate the association of CPCs with mortality and explore the association between physical activity (PA) and CPCs.
METHODS: 1751 individuals from the Framingham Offspring cohort (66 ± 9 years [40-92 years], 54% female) were included in the study. CPCs (CD34+, CD34+CD133+, CD34+CD133+KDR+) were measured by flow cytometry. Multivariable Cox regression analyses were performed to investigate relationship of CPCs with future CV event and mortality. Multivariate regression analyses were performed to determine the relationship between self-reported PA and CPC counts.
RESULTS: Following adjustment for standard risk factors, there was an inverse association between CD34+ CPCs and all-cause mortality (hazard ratio (HR) per unit increase in CD34+, 0.79; 95% CI 0.64-0.98, p = 0.036). CD34+CD133+ CPCs were inversely associated with CV mortality (HR 0.63, 95% CI 0.44-0.91, p = 0.013). Associations of CD34+ and CD34+CD133+ with mortality were strongest in participants with pre-existing CVD. PA was associated with CD34+ CPCs only in CVD participants (PA Index: β = 0.176, p = 0.003; moderate-to-vigorous [MVPA]: β = 0.159, p = 0.007). This relationship was maintained after adjustment for confounding variables.
CONCLUSIONS: A higher number of CD34+ and CD34+ CD133+ CPCs was inversely associated with all-cause and CV mortality. These associations were strongest in participants with CVD. PA is independently associated with CD34+ CPCs in individuals with CVD only, suggestive of greater benefit for this population group.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Endothelium; Mortality; Physical activity; Progenitor cells

Year:  2021        PMID: 34340831     DOI: 10.1016/j.atherosclerosis.2021.07.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

Review 1.  The impact of different forms of exercise on circulating endothelial progenitor cells in cardiovascular and metabolic disease.

Authors:  Panagiotis Ferentinos; Costas Tsakirides; Michelle Swainson; Adam Davison; Marrissa Martyn-St James; Theocharis Ispoglou
Journal:  Eur J Appl Physiol       Date:  2022-01-12       Impact factor: 3.078

Review 2.  Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review.

Authors:  Paul Philipp Heinisch; Corina Bello; Maximilian Y Emmert; Thierry Carrel; Martina Dreßen; Jürgen Hörer; Bernhard Winkler; Markus M Luedi
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

3.  Association between circulating CD34-positive cell count and height loss among older men.

Authors:  Yuji Shimizu; Shin-Ya Kawashiri; Kenichi Nobusue; Fumiaki Nonaka; Mami Tamai; Yukiko Honda; Hirotomo Yamanashi; Seiko Nakamichi; Masahiko Kiyama; Naomi Hayashida; Yasuhiro Nagata; Takahiro Maeda
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

4.  Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units.

Authors:  Roberto Scicali; Giuseppe Mandraffino; Michele Scuruchi; Alberto Lo Gullo; Antonino Di Pino; Viviana Ferrara; Carmela Morace; Caterina Oriana Aragona; Giovanni Squadrito; Francesco Purrello; Salvatore Piro
Journal:  Biomedicines       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.